ReviewMolecular cancer2023

Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials.

Xianjing Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.